Eto M - Search Results

1

Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study.

Tanegashima T, Shiota M, Fujiyama N, Narita S, Habuchi T, Fukuchi G, Takamatsu D, Oda Y, Miyake H, Takahashi M, Oya M, Tsuchiya N, Masumori N, Matsuyama H, Obara W, Shinohara N, Fujimoto K, Nozawa M, Ohba K, Ohyama C, Hashine K, Akamatsu S, Kamba T, Mita K, Gotoh M, Tatarano S, Fujisawa M, Tomita Y, Mukai S, Ito K, Tokunaga S, Eto M. Tanegashima T, et al. Among authors: eto m. J Immunol. 2024 Jul 1;213(1):23-28. doi: 10.4049/jimmunol.2300308. J Immunol. 2024. PMID: 38758119 Free PMC article.

2

Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice.

Eto M, Mayumi H, Tomita Y, Yoshikai Y, Nishimura Y, Maeda T, Ando T, Nomoto K. Eto M, et al. J Immunol. 1991 Mar 1;146(5):1402-9. J Immunol. 1991. PMID: 1671578

3

Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.

Nishimura Y, Mayumi H, Tomita Y, Eto M, Maeda T, Nomoto K. Nishimura Y, et al. Among authors: eto m. J Immunol. 1991 Apr 15;146(8):2639-47. J Immunol. 1991. PMID: 1707914

4

Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.

Tomita Y, Mayumi H, Eto M, Nomoto K. Tomita Y, et al. Among authors: eto m. J Immunol. 1990 Mar 15;144(6):2425-35. J Immunol. 1990. PMID: 1968930

5

Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?

Tomita Y, Mayumi H, Eto M, Nomoto K. Tomita Y, et al. Among authors: eto m. J Immunol. 1990 Jan 15;144(2):463-73. J Immunol. 1990. PMID: 2136891

6

Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens.

Eto M, Mayumi H, Tomita Y, Yoshikai Y, Nomoto K. Eto M, et al. J Exp Med. 1990 Jan 1;171(1):97-113. doi: 10.1084/jem.171.1.97. J Exp Med. 1990. PMID: 2136907 Free PMC article.

7

Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion.

Eto M, Mayumi H, Tomita Y, Yoshikai Y, Nishimura Y, Nomoto K. Eto M, et al. J Immunol. 1990 Sep 1;145(5):1303-10. J Immunol. 1990. PMID: 2143514

8

Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.

Tomita Y, Nishimura Y, Harada N, Eto M, Ayukawa K, Yoshikai Y, Nomoto K. Tomita Y, et al. Among authors: eto m. J Immunol. 1990 Dec 15;145(12):4026-36. J Immunol. 1990. PMID: 2147933

9

The requirement of intrathymic mixed chimerism and clonal deletion for a long-lasting skin allograft tolerance in cyclophosphamide-induced tolerance.

Eto M, Mayumi H, Tomita Y, Yoshikai Y, Nishimura Y, Nomoto K. Eto M, et al. Eur J Immunol. 1990 Sep;20(9):2005-13. doi: 10.1002/eji.1830200919. Eur J Immunol. 1990. PMID: 2209702

10

Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody.

Maeda T, Eto M, Lin T, Nishimura Y, Kong YY, Nomoto K, Nomoto K. Maeda T, et al. Among authors: eto m. J Immunol. 1994 Nov 1;153(9):4311-20. J Immunol. 1994. PMID: 7930630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,000 results

Search Page

Filters